相关实验视频

Updated: Sep 13, 2025

The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro

The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro

Published on: September 18, 2017

来自Angio-miRNA修饰的介质细胞干细胞的细胞外囊的血管性能力

Yoshiki Wada¹, Toshifumi Kudo¹, Anri Koyanagi²

¹Department of Vascular Surgery, Institute of Science Tokyo, Tokyo, Japan.

Tissue engineering and regenerative medicine

|July 31, 2025

概括

基因改造的细胞外囊泡 (EVs) 显示出治疗慢性四肢缺血症的前景. 在实验室和动物研究中,结合特定的修饰EV显著增强了血管形成.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
分子生物学分子生物学

背景情况:

细胞外囊泡 (EVs) 为慢性肢体威胁性缺血症提供了一个有前途的再生疗法.
这项研究调查了由介质细胞 (MSC) 改造的EVs的血管新生潜力,通过修改它们的microRNA (miRNA) 含量.

研究的目的:

评估从转基因MSC中衍生出的EVs在促进血管新生治疗肢体缺血的有效性.
在EV中识别特定的Angio-miRNA,这些Angio-miRNA有助于治疗效果.

主要方法:

通过使用lentiviral载体来过度表达特定的Angio-miRNAs (miRNA-126, -135b, -210) 的MSCs被基因修饰.
隔离和鉴定了EVs;其血管生成潜力在体外使用人类静脉内皮细胞 (HUVECs) 和体内通过注射到诱导缺血症的小鼠的后肢中来评估.

主要成果:

证实了MSC中的血管-miRNAs的过度表达及其随后的纳入EVs.
来自修改后的MSC的EVs在体外显著增强了HUVEC中的管形成.
在体内研究表明,相结合的修改EV (EV126 + EV135b) 与对照或单个修改EV相比,在缺血性后肢中显著改善了血液 perfusion 和毛细血管密度.

结论:

来自转基因MSC的EV具有显著的血管新生特性.
与单个修改EV或原生EV相比,修改EV的组合显示出治疗肢体缺血的优越治疗潜力.

关键词:

血管新生的产生.慢性四肢威胁性缺血症慢性四肢威胁性缺血症细胞外囊泡中的细胞外囊泡.微RNAs是一种微RNA.

更多相关视频

Setting a Successful Sorting for Extracellular Vesicle Isolation

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Published on: May 3, 2024

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...